The influence of orexins on ethanol-induced behavioral sensitization in male mice

Neuroscience Letters

Volumn 551, Issue , 2013, Pages 84-88

  Macedo, Giovana Camila ^a   Kawakami, Suzi Emiko ^a   Vignoli, Thiago ^a   Sinigaglia Coimbra, Rita ^a   Suchecki, Deborah ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Behavioral sensitization; Ethanol; Fos; Immunohistochemistry; Orexin type 1 receptor

Indexed keywords

ALCOHOL; OREXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SENSITIZATION; CONTROLLED STUDY; DRUG DEPENDENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATERAL HYPOTHALAMUS; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

BEHAVIORAL SENSITIZATION; ETHANOL; FOS; IMMUNOHISTOCHEMISTRY; OREXIN TYPE 1 RECEPTOR;

ANIMALS; ETHANOL; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MOTOR ACTIVITY; NEURONS; NEUROPEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 84882238554     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.07.010     Document Type: Article

References (42)

1. Abrahao K.P., Quadros I.M., Souza-Formigoni M.L. Individual differences to repeated ethanol administration may predict locomotor response to other drugs, and vice versa. Behavioural Brain Research 2009, 197:404-410.
2. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
3. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:19168-19173.
4. Brown R.M., Yon-Seng Khoo S., Lawrence A.J. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats. International Journal of Neuropsychopharmacology 2013, 1-13.
5. Bubser M., Fadel J.R., Jackson L.L., Meador-Woodruff J.H., Jing D., Deutch A.Y. Dopaminergic regulation of orexin neurons. European Journal of Neuroscience 2005, 21:2993-3001.
6. Dayas C.V., McGranahan T.M., Martin-Fardon R., Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biological Psychiatry 2008, 63:152-157.
7. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:322-327.
8. Ding Z.M., Rodd Z.A., Engleman E.A., McBride W.J. Sensitization of ventral tegmental area dopamine neurons to the stimulating effects of ethanol. Alcoholism: Clinical and Experimental Research 2009, 33:1571-1581.
9. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, 100pp. Academic Press, San Diego.
10. Harris G.C., Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends in Neurosciences 2006, 29:571-577.
11. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
12. Hoever P., Dorffner G., Beneš H., Penzel T., Danker-Hopfe H., Barbanoj M.J., Pillar G., Saletu B., Polo O., Kunz D., Zeitlhofer J., Berg S., Partinen M., Bassetti C.L., Högl B., Ebrahim I.O., Holsboer-Trachsler E., Bengtsson H., Peker Y., Hemmeter U.M., Chiossi E., Hajak G., Dingemanse J. Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clinical Pharmacology and Therapeutics 2012, 91:975-985.
13. Hutcheson D.M., Quarta D., Halbout B., Rigal A., Valerio E., Heidbreder C. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward. Behavioural Pharmacology 2011.
14. Kalivas P.W. A role for glutamate transmission in addiction to psychostimulants. Addiction Biology 2000, 5:325-329.
15. Kawakami S.E., Quadros I.M., Takahashi S., Suchecki D. Long maternal separation accelerates behavioural sensitization to ethanol in female, but not in male mice. Behavioural Brain Research 2007, 184:109-116.
16. Kim A.K., Brown R.M., Lawrence A.J. The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship. Frontiers in Behavioral Neuroscience 2012, 6:78.
17. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. Journal of Neuroscience 2003, 23:7-11.
18. Laorden M.L., Ferenczi S., Pintér-Kübler B., González-Martín L.L., Lasheras M.C., Kovács K.J., Milanés M.V., Núñez C. Hypothalamic orexin - a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One 2012, 7:e36871.
19. Lawrence A.J. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Research 2010, 1314:124-129.
20. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., Oldfield B. The orexin system regulates alcohol-seeking in rats. British Journal of Pharmacology 2006, 148:752-759.
21. Mahler S.V., Smith R.J., Moorman D.E., Sartor G.C., Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Progress in Brain Research 2012, 198:79-121.
22. Mang G.M., Dürst T., Bürki H., Imobersteg S., Abramowski D., Schuepbach E., Hoyer D., Fendt M., Gee C.E. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors. Sleep 2012, 35:1625-1635.
23. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. Journal of Comparative Neurology 2001, 435:6-25.
24. Millan E.Z., Furlong T.M., McNally G.P. Accumbens shell-hypothalamus interactions mediate extinction of alcohol seeking. Journal of Neuroscience 2010, 30:4626-4635.
25. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. Journal of Neuroscience 1998, 18:9996-10015.
26. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research 1997, 25:192-216.
27. Plaza-Zabala A., Martín-García E., de Lecea L., Maldonado R., Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. Journal of Neuroscience 2010, 30:2300-2310.
28. Quarta D., Valerio E., Hutcheson D.M., Hedou G., Heidbreder C. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization. Neurochemistry International 2010, 56:11-15.
29. Robinson T.E., Berridge K.C. Incentive-sensitization and addiction. Addiction (Abingdon, England) 2001, 96:103-114.
30. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain research 1993, 18:247-291.
31. Sakurai T. Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. CNS & Neurological Disorders Drug Targets 2006, 5:313-325.
32. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
33. Sanchis-Segura C., Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addiction biology 2006, 11:2-38.
34. Schneider E.R., Rada P., Darby R.D., Leibowitz S.F., Hoebel B.G. Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcoholism, Clinical and Experimental Research 2007, 31:1858-1865.
35. Sharf R., Sarhan M., Dileone R.J. Role of orexin/hypocretin in dependence and addiction. Brain Research 2010, 1314:130-138.
36. Shoblock J.R., Welty N., Aluisio L., Fraser I., Motley S.T., Morton K., Palmer J., Bonaventure P., Carruthers N.I., Lovenberg T.W., Boggs J., Galici R. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology 2011, 215:191-203.
37. Smith R.J., See R.E., Aston-Jones G. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. European Journal of Neuroscience 2009, 30:493-503.
38. Thompson J.L., Borgland S.L. A role for hypocretin/orexin in motivation. Behavioural Brain Research 2011, 217:446-453.
39. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Letters 1998, 438:71-75.
40. Uramura K., Funahashi H., Muroya S., Shioda S., Takigawa M., Yada T. Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 2001, 12:1885-1889.
41. Wang B., You Z.B., Wise R.A. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biological Psychiatry 2009, 65:857-862.
42. Winrow C.J., Tanis K.Q., Reiss D.R., Rigby A.M., Uslaner J.M., Uebele V.N., Doran S.M., Fox S.V., Garson S.L., Gotter A.L., Levine D.M., Roecker A.J., Coleman P.J., Koblan K.S., Renger J.J. Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 2010, 58:185-194.